Favipiravir treatment in non-severe COVID-19: promising results from multicenter propensity score-matched study (FAVICOV)

This study aimed to evaluate the efficacy of favipiravir (FPV) in preventing the development of severe COVID-19 in patients with mild-to-moderate symptoms. The study evaluated 1037 COVID-19 patients treated with FPV or standard treatment between April and September 2021, analyzed by propensity score...

Descripción completa

Detalles Bibliográficos
Autores principales: Siripongboonsitti, Taweegrit, Muadchimkaew, Marisa, Tawinprai, Kriangkrai, Issaranon, Ornisa, Meepholkij, Wichuda, Arttawejkul, Pureepat, Vararungzarit, Apiradee, Thavornwattana, Kaewklao, Mahanonda, Nithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492810/
https://www.ncbi.nlm.nih.gov/pubmed/37689754
http://dx.doi.org/10.1038/s41598-023-42195-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492810/
https://www.ncbi.nlm.nih.gov/pubmed/37689754
http://dx.doi.org/10.1038/s41598-023-42195-x

Ejemplares similares